The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the supply of Escitalopram Oxalate Tablets in various dosages and package sizes, with a one-year base period and four one-year option periods, for a total ceiling value of $48,442,917.75. The contracted items will be distributed through the VA's and Department of Defense's (DoD) Pharmaceutical Prime Vendor Programs, supporting the healthcare needs of veterans, military personnel, and other federal beneficiaries across the VA, DoD, Bureau of Prisons, and Indian Health Service. The original pre-solicitation notice indicated that the VA planned to issue a Request for Proposal (RFP) for an unrestricted procurement, with no set-aside designations, to ensure an uninterrupted supply of the drug. The contract requires the awardee to have a unique National Drug Code (NDC) number and provide the exact name by which the drug will be supplied.
Exelan Pharmaceuticals is an experienced federal contractor, holding multiple IDCs and a Federal Supply Schedule contract for pharmaceuticals and drugs. The company specializes in manufacturing, distributing, and repackaging pharmaceutical medications for government customers, with a focus on serving the VA, DoD, and other federal healthcare agencies. This IDC award further strengthens Exelan's position as a key supplier of critical medications and repackaging services to support the healthcare initiatives of various federal agencies.
Generated 2/11/25, 10:07 AM